The role of the cytokine SDF-1 (CXCL12) in bone marrow mesenchymal stem/progenitor cells (BMSCs) function and bone homeostasis was the focus of our previous work in the original PO1 Project 3. The novel outcomes from those studies are driving the current goals in this competitive renewal. The mechanisms involved in aging-related osteoporosis remain poorly defined, however, recent studies from our group, and others, suggest that it is a stem cell disease. A critical problem is that aging triggers impaired localization, proliferation, survival, and differentiation of the osteogenic progenitor cell population in the bone marrow (BM), specifically BMSCs. A critical barrier to preventing these changes is identifying key regulatory pathways, and being able to alter or correct them. Our goal is to use information generated from our original PO1, where we have identified epigenetic changes in a subset of miRNAs in BMSCs, and to target these miRNAs to limit, or reverse, bone loss. Age-associated changes in SDF-1 systemically alter epigenetic regulatory systems, specifically miRNAs, in BMSCs, which in turn directly, and via nutrient signaling pathways, affect cell survival, osteogenesis and bone formation. SDF-1 is tightly regulated translationally, transcriptionally, and post- transcriptionally. We have identified age-associated changes in the SDF-1 axis. Here we show that SDF-1 is not only a target of novel age-associated miRNA epigenetic regulation, but itself alters expression of miRNAs that change with age in BMSCs and target the SDF-1 axis. Significantly, a key miRNA that we identified to increase with age in BMSCs (miR-29b-1-5p) belongs to the miR29 family of miRNAs that have been shown to be critical in extracellular matrix homeostasis and osteogenesis. What is novel, and a challenge to the existing paradigm, is that miR29b-1-5p is the ?passenger strand?, which is normally thought to be degraded leaving the complementary miR-29b-1-3p ?guide strand? as the functional miRNA. Understanding the mechanism that drives this previously unknown age-associated increase in the passenger strand is a critical goal because we have demonstrated that miR29b-1-5p regulates SDF-1 expression and suppresses BMSC osteogenesis and survival pathways. We propose to test the hypothesis that the elevated age-related levels of circulating SDF-1 and decreased bone marrow compartment levels and activity regulate the increased expression of miR-29b-1- 5p and downstream effects on bone homeostasis. Our objectives are to test new hypotheses derived from the findings of the original PO1 by manipulating the miRNAs we identified as changing with age in human/murine BMSCs to determine their effects on bone formation and turnover in vivo and at the molecular level on BMSC osteogenic function. We will test novel methods to reduce expression of these miRNAs, including altering nutritional pathways leading to bone loss by using specific forms of dietary amino acid and delivering synthetic anti-miRNAs to inhibit them. The impact of this project will be demonstrating the role of age-associated changes of BMSC miRNAs and identifying novel targets for reducing, or reversing, age related bone loss.

Public Health Relevance

Hill, William D. - PI Project 3 We have identified novel microRNA molecules that are increased with age in bone marrow stem cells. These molecules block genes needed to make new bone. Importantly, they appear to be critical in making the stem cells dysfunctional, and may lead to age-related bone loss and osteoporosis. This grant application is to test if we can use novel methods to reduce these miRNAs as we age and begin to develop new therapies to treat osteoporosis.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Augusta University
United States
Zip Code
Bollag, Wendy B; Choudhary, Vivek; Zhong, Qing et al. (2018) Deletion of protein kinase D1 in osteoprogenitor cells results in decreased osteogenesis in vitro and reduced bone mineral density in vivo. Mol Cell Endocrinol 461:22-31
Kim, Beom-Jun; Lee, Seung Hun; Kwak, Mi Kyung et al. (2018) Inverse relationship between serum hsCRP concentration and hand grip strength in older adults: a nationwide population-based study. Aging (Albany NY) 10:2051-2061
Kim, B-J; Lee, S H; Isales, C M et al. (2018) The positive association of total protein intake with femoral neck strength (KNHANES IV). Osteoporos Int 29:1397-1405
Ding, Ke-Hong; Cain, Michael; Davis, Michael et al. (2018) Amino acids as signaling molecules modulating bone turnover. Bone 115:15-24
Kolhe, Ravindra; Mondal, Ashis K; Pundkar, Chetan et al. (2018) Modulation of miRNAs by Vitamin C in Human Bone Marrow Stromal Cells. Nutrients 10:
Yu, Kanglun; Sellman, David P; Bahraini, Anoosh et al. (2018) Mechanical loading disrupts osteocyte plasma membranes which initiates mechanosensation events in bone. J Orthop Res 36:653-662
Kesterke, Matthew J; Judd, Margaret A; Mooney, Mark P et al. (2018) Maternal environment and craniofacial growth: geometric morphometric analysis of mandibular shape changes with in utero thyroxine overexposure in mice. J Anat 233:46-54
Howie, R Nicole; Herberg, Samuel; Durham, Emily et al. (2018) Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model. Int J Oral Sci 10:25
Elsayed, Ranya; Abraham, Pheba; Awad, Mohamed E et al. (2018) Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function. Bone 110:141-149
Murphy, Cameron; Withrow, Joseph; Hunter, Monte et al. (2018) Emerging role of extracellular vesicles in musculoskeletal diseases. Mol Aspects Med 60:123-128

Showing the most recent 10 out of 51 publications